S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
Log in

Tetraphase Pharmaceuticals News Headlines (NASDAQ:TTPH)

$2.26
-0.01 (-0.44 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
$2.21
Now: $2.26
$2.31
50-Day Range
$2.18
MA: $2.55
$3.84
52-Week Range
$1.99
Now: $2.26
$29.00
Volume168,474 shs
Average Volume205,716 shs
Market Capitalization$7.83 million
P/E RatioN/A
Dividend YieldN/A
Beta2.4

Headlines

Tetraphase Pharmaceuticals (NASDAQ TTPH) News Headlines

Source:
DateHeadline
Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) Sees Large Increase in Short InterestTetraphase Pharmaceuticals Inc (NASDAQ:TTPH) Sees Large Increase in Short Interest
www.americanbankingnews.com - February 12 at 12:52 AM
Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) Receives Consensus Rating of "Buy" from AnalystsTetraphase Pharmaceuticals Inc (NASDAQ:TTPH) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - February 7 at 2:38 AM
Tetraphase Pharma down 19% premarket on equity offeringTetraphase Pharma down 19% premarket on equity offering
seekingalpha.com - January 23 at 7:57 AM
Tetraphase Pharmaceuticals Announces $17.5 Million of Financings Priced At-the-MarketTetraphase Pharmaceuticals Announces $17.5 Million of Financings Priced At-the-Market
finance.yahoo.com - January 22 at 9:56 PM
Edited Transcript of TTPH earnings conference call or presentation 12-Nov-19 9:30pm GMTEdited Transcript of TTPH earnings conference call or presentation 12-Nov-19 9:30pm GMT
finance.yahoo.com - November 16 at 12:12 AM
Tetraphase Pharmaceuticals, Inc. (TTPH) CEO Larry Edwards on Q3 2019 Results - Earnings Call TranscriptTetraphase Pharmaceuticals, Inc. (TTPH) CEO Larry Edwards on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 12 at 10:56 PM
Tetraphase Pharmaceuticals (TTPH) Reports Q3 Loss, Tops Revenue EstimatesTetraphase Pharmaceuticals (TTPH) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 12 at 10:56 PM
Tetraphase Pharmaceuticals Reports Third Quarter 2019 Financial Results and Highlights Recent Corporate DevelopmentsTetraphase Pharmaceuticals Reports Third Quarter 2019 Financial Results and Highlights Recent Corporate Developments
finance.yahoo.com - November 12 at 5:56 PM
The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medicals Earnings BeatThe Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat
www.benzinga.com - November 12 at 7:54 AM
Tetraphase Pharmaceuticals to Host Third Quarter 2019 Financial Results Conference CallTetraphase Pharmaceuticals to Host Third Quarter 2019 Financial Results Conference Call
finance.yahoo.com - November 5 at 8:58 AM
Tetraphase Pharmaceuticals Announces Completion of $8 Million Registered Direct Offering Priced At-the-MarketTetraphase Pharmaceuticals Announces Completion of $8 Million Registered Direct Offering Priced At-the-Market
finance.yahoo.com - November 1 at 5:32 PM
Tetraphase down 12% premarket on equity offeringTetraphase down 12% premarket on equity offering
seekingalpha.com - October 30 at 12:39 PM
Tetraphase Pharmaceuticals Announces $8 Million Registered Direct Offering Priced At-the-MarketTetraphase Pharmaceuticals Announces $8 Million Registered Direct Offering Priced At-the-Market
finance.yahoo.com - October 30 at 12:38 PM
Tetraphase Pharma up 23% after reverse splitTetraphase Pharma up 23% after reverse split
seekingalpha.com - September 27 at 4:12 PM
Tetraphase Pharmaceuticals Announces Reverse Stock SplitTetraphase Pharmaceuticals Announces Reverse Stock Split
finance.yahoo.com - September 26 at 7:52 AM
Tetraphase Pharmaceuticals to Present XERAVA™ (Eravacycline) Data at IDWeek 2019Tetraphase Pharmaceuticals to Present XERAVA™ (Eravacycline) Data at IDWeek 2019
finance.yahoo.com - September 25 at 7:36 AM
Tetraphase: Add To Watch List On Potential Antibiotic SalesTetraphase: Add To Watch List On Potential Antibiotic Sales
seekingalpha.com - September 19 at 4:13 PM
What Kind Of Shareholder Owns Most Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) Stock?What Kind Of Shareholder Owns Most Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) Stock?
finance.yahoo.com - September 13 at 2:50 PM
Edited Transcript of TTPH earnings conference call or presentation 8-Aug-19 8:30pm GMTEdited Transcript of TTPH earnings conference call or presentation 8-Aug-19 8:30pm GMT
finance.yahoo.com - August 10 at 5:58 PM
Tetraphase Pharmaceuticals Inc (TTPH) Q2 2019 Earnings Call TranscriptTetraphase Pharmaceuticals Inc (TTPH) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 9 at 7:19 PM
Tetraphase Pharmaceuticals, Inc. (TTPH) CEO Larry Edwards on Q2 2019 Results - Earnings Call TranscriptTetraphase Pharmaceuticals, Inc. (TTPH) CEO Larry Edwards on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 8 at 7:18 PM
Tetraphase Pharmaceuticals Reports Second Quarter 2019 Financial Results and Highlights Recent Corporate DevelopmentsTetraphase Pharmaceuticals Reports Second Quarter 2019 Financial Results and Highlights Recent Corporate Developments
finance.yahoo.com - August 8 at 7:18 PM
Tetraphase Pharmaceuticals (TTPH) Reports Q2 Loss, Lags Revenue EstimatesTetraphase Pharmaceuticals (TTPH) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 8 at 7:18 PM
Earnings Preview: Tetraphase Pharmaceuticals (TTPH) Q2 Earnings Expected to DeclineEarnings Preview: Tetraphase Pharmaceuticals (TTPH) Q2 Earnings Expected to Decline
finance.yahoo.com - July 25 at 5:57 PM
New Studies Highlight Activity of XERAVA™ Against Gram-Negative and Gram-Positive Clinical Isolates, Including Multidrug-Resistant PathogensNew Studies Highlight Activity of XERAVA™ Against Gram-Negative and Gram-Positive Clinical Isolates, Including Multidrug-Resistant Pathogens
finance.yahoo.com - June 24 at 5:08 PM
What You Should Know About Tetraphase Pharmaceuticals, Inc.s (NASDAQ:TTPH) Financial StrengthWhat You Should Know About Tetraphase Pharmaceuticals, Inc.'s (NASDAQ:TTPH) Financial Strength
finance.yahoo.com - June 13 at 6:58 PM
What You Should Know About Tetraphase Pharmaceuticals, Inc.'s (NASDAQ:TTPH) Financial StrengthWhat You Should Know About Tetraphase Pharmaceuticals, Inc.'s (NASDAQ:TTPH) Financial Strength
finance.yahoo.com - June 13 at 6:58 PM
Tetraphase Pharmaceuticals Highlights Data at Upcoming American Society for Microbiology Microbe 2019 Annual MeetingTetraphase Pharmaceuticals Highlights Data at Upcoming American Society for Microbiology Microbe 2019 Annual Meeting
finance.yahoo.com - June 13 at 9:16 AM
Tetraphase Pharmaceuticals Announces Corporate Reorganization Aimed at Maximizing XERAVA™ (Eravacycline) Commercial OpportunityTetraphase Pharmaceuticals Announces Corporate Reorganization Aimed at Maximizing XERAVA™ (Eravacycline) Commercial Opportunity
finance.yahoo.com - June 12 at 4:22 PM
Tetraphase Pharmaceuticals Announces New XERAVA™ (eravacycline) Data at the 39th Annual Surgical Infection Society MeetingTetraphase Pharmaceuticals Announces New XERAVA™ (eravacycline) Data at the 39th Annual Surgical Infection Society Meeting
finance.yahoo.com - June 10 at 10:01 AM
Tetraphase Pharmaceuticals to Present Data at the 39th Annual Meeting of the Surgical Infection SocietyTetraphase Pharmaceuticals to Present Data at the 39th Annual Meeting of the Surgical Infection Society
finance.yahoo.com - June 6 at 6:04 PM
Tetraphase Pharmaceuticals Inc (TTPH) Q1 2019 Earnings Call TranscriptTetraphase Pharmaceuticals Inc (TTPH) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 9 at 6:49 PM
Tetraphase Pharmaceuticals (TTPH) CEO Guy Macdonald on Q1 2019 Results - Earnings Call TranscriptTetraphase Pharmaceuticals' (TTPH) CEO Guy Macdonald on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 9:18 AM
Edited Transcript of TTPH earnings conference call or presentation 8-May-19 8:30pm GMTEdited Transcript of TTPH earnings conference call or presentation 8-May-19 8:30pm GMT
finance.yahoo.com - May 9 at 9:18 AM
Tetraphase Pharmaceuticals (TTPH) Reports Q1 Loss, Misses Revenue EstimatesTetraphase Pharmaceuticals (TTPH) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 8 at 6:51 PM
Tetraphase Pharmaceuticals to Present Data at the 22nd Annual MAD-ID MeetingTetraphase Pharmaceuticals to Present Data at the 22nd Annual MAD-ID Meeting
finance.yahoo.com - May 2 at 9:24 AM
Tetraphase Pharmaceuticals to Participate in Upcoming Investor ConferencesTetraphase Pharmaceuticals to Participate in Upcoming Investor Conferences
finance.yahoo.com - April 30 at 9:10 AM
Easy Come, Easy Go: How Tetraphase Pharmaceuticals (NASDAQ:TTPH) Shareholders Got Unlucky And Saw 90% Of Their Cash EvaporateEasy Come, Easy Go: How Tetraphase Pharmaceuticals (NASDAQ:TTPH) Shareholders Got Unlucky And Saw 90% Of Their Cash Evaporate
finance.yahoo.com - April 28 at 5:20 PM
Will Tetraphase Pharmaceuticals (TTPH) Report Negative Q1 Earnings? What You Should KnowWill Tetraphase Pharmaceuticals (TTPH) Report Negative Q1 Earnings? What You Should Know
finance.yahoo.com - April 25 at 6:24 PM
Tetraphase Pharmaceuticals to Present Data at the 29th European Congress of Clinical Microbiology and Infectious DiseasesTetraphase Pharmaceuticals to Present Data at the 29th European Congress of Clinical Microbiology and Infectious Diseases
finance.yahoo.com - April 8 at 10:53 AM
Robbins Arroyo LLP: Tetraphase Pharmaceuticals, Inc. (TTPH) Accused of Misleading ShareholdersRobbins Arroyo LLP: Tetraphase Pharmaceuticals, Inc. (TTPH) Accused of Misleading Shareholders
finance.yahoo.com - April 5 at 6:47 PM
Tetraphase Pharmaceuticals Presents Preclinical Data on TP-2846, a Novel Drug Candidate for Acute Myeloid LeukemiaTetraphase Pharmaceuticals Presents Preclinical Data on TP-2846, a Novel Drug Candidate for Acute Myeloid Leukemia
www.businesswire.com - April 3 at 10:32 AM
Edited Transcript of TTPH earnings conference call or presentation 14-Mar-19 8:30pm GMTEdited Transcript of TTPH earnings conference call or presentation 14-Mar-19 8:30pm GMT
finance.yahoo.com - March 18 at 6:49 PM
BTIG likes Arcus Bio in premarket analyst actionBTIG likes Arcus Bio in premarket analyst action
seekingalpha.com - March 18 at 9:05 AM
Tetraphase Pharmaceuticals Reports Fourth Quarter and Full-Year 2018 Financial Results and Highlights Achievements and Key 2019 Milestones - Business WireTetraphase Pharmaceuticals Reports Fourth Quarter and Full-Year 2018 Financial Results and Highlights Achievements and Key 2019 Milestones - Business Wire
www.businesswire.com - March 16 at 9:45 AM
Tetraphase Pharmaceuticals, Inc. (TTPH) CEO Guy Macdonald on Q4 2018 Results - Earnings Call Transcript - Seeking AlphaTetraphase Pharmaceuticals, Inc. (TTPH) CEO Guy Macdonald on Q4 2018 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - March 16 at 9:45 AM
Tetraphase Pharmaceuticals, Inc. to Host Earnings CallTetraphase Pharmaceuticals, Inc. to Host Earnings Call
finance.yahoo.com - March 14 at 6:28 PM
Tetraphase Pharmaceuticals Reports Fourth Quarter and Full-Year 2018 Financial Results and Highlights Achievements and Key 2019 MilestonesTetraphase Pharmaceuticals Reports Fourth Quarter and Full-Year 2018 Financial Results and Highlights Achievements and Key 2019 Milestones
finance.yahoo.com - March 14 at 6:28 PM
Tetraphase: 4Q Earnings SnapshotTetraphase: 4Q Earnings Snapshot
finance.yahoo.com - March 14 at 6:28 PM
Tetraphase Pharmaceuticals, Inc. (TTPH) After Hours TradingTetraphase Pharmaceuticals, Inc. (TTPH) After Hours Trading
www.nasdaq.com - March 14 at 9:36 AM
This page was last updated on 2/21/2020 by MarketBeat.com Staff

Featured Article: Holder of Record

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel